Roche Expands PCR Licensing Through Agreements With Applera

Roche Diagnostics announced it has reached an agreement with Applera to expand its PCR licensing program to incorporate enabling patents for real-time PCR and other important PCR-related technology. Under the terms of the agreements, the Applied Biosystems Group (an Applera business) will be authorized by Roche to be the sole licensor of Roche patents covering reagents and methods for practicing PCR and real-time PCR in the life science research and applied fields. Roche has also granted Applera a diagnostics license, with no right to sublicense, under Roche's nucleic acid technology patents.

Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=522916XSL_NEWSML_TO_NEWSML_WEB.xml)